Pds Biotechnology Corp (PDSB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 60,625 | 65,199 | 73,820 | 71,642 | 52,985 |
| TOTAL | $63,351 | $67,973 | $76,480 | $74,411 | $55,743 |
| Non-Current Assets | |||||
| PPE Net | 144 | 148 | N/A | N/A | N/A |
| Other Non-Current Assets | 260 | 327 | 528 | 475 | 258 |
| TOTAL | $403 | $475 | $528 | $475 | $258 |
| Total Assets | $63,754 | $68,449 | $77,008 | $74,887 | $56,001 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,415 | 2,072 | 1,219 | 2,037 | 1,878 |
| Accrued Expenses | 3,376 | 1,858 | 8,314 | 2,429 | 2,303 |
| TOTAL | $7,904 | $4,130 | $9,821 | $4,841 | $4,516 |
| Non-Current Liabilities | |||||
| Long Term Debt | 23,254 | 23,143 | 23,021 | 22,910 | N/A |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 60 |
| TOTAL | $23,406 | $23,308 | $23,185 | $22,987 | $60 |
| Total Liabilities | $31,310 | $27,438 | $33,006 | $27,828 | $4,576 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 30,868 | 30,824 | 30,724 | 28,509 | 28,459 |
| Common Shares | 10 | 10 | 10 | 9 | 9 |
| Retained earnings | -122,753 | -111,218 | -101,558 | -82,421 | -74,996 |
| TOTAL | $32,444 | $41,011 | $44,002 | $47,059 | $51,425 |
| Total Liabilities And Equity | $63,754 | $68,449 | $77,008 | $74,887 | $56,001 |